These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 32111093)

  • 1. Lung Cancer (LC) in HIV Positive Patients: Pathogenic Features and Implications for Treatment.
    Frega S; Ferro A; Bonanno L; Guarneri V; Conte P; Pasello G
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32111093
    [No Abstract]   [Full Text] [Related]  

  • 2. Managing Pharmacotherapy in People Living With HIV and Concomitant Malignancy.
    Olin JL; Klibanov O; Chan A; Spooner LM
    Ann Pharmacother; 2019 Aug; 53(8):812-832. PubMed ID: 30770025
    [No Abstract]   [Full Text] [Related]  

  • 3. [HIV and cancer: Update 2020].
    Abbar B; Veyri M; Solas C; Poizot-Martin I; Spano JP
    Bull Cancer; 2020 Jan; 107(1):21-29. PubMed ID: 31980144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lung cancer in HIV-infected patients].
    Domblides C; Canellas A; Wislez M; Fallet V; Antoine M; Crequit P; Cadranel J; Lavolé A
    Bull Cancer; 2018 Jan; 105(1):111-119. PubMed ID: 29269175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer in the HIV-Infected Host: Epidemiology and Pathogenesis in the Antiretroviral Era.
    Brickman C; Palefsky JM
    Curr HIV/AIDS Rep; 2015 Dec; 12(4):388-96. PubMed ID: 26475669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic treatment and radiotherapy for patients with non-small cell lung cancer (NSCLC) and HIV infection - A systematic review.
    Brandão M; Durieux V; Auprih M; Fozza A; Dauby N; Cuccia F; Aspeslagh S; Verhaert M; Giaj-Levra N
    Lung Cancer; 2023 Apr; 178():75-86. PubMed ID: 36806897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating cancer with immunotherapy in HIV-positive patients: A challenging reality.
    Guaitoli G; Baldessari C; Maur M; Mussini C; Meschiari M; Barbieri F; Cascinu S; Bertolini F
    Crit Rev Oncol Hematol; 2020 Jan; 145():102836. PubMed ID: 31918216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comorbidities and co-medications among 28 089 people living with HIV: A nationwide cohort study from 2009 to 2019 in Japan.
    Naito T; Suzuki M; Fukushima S; Yuda M; Fukui N; Tsukamoto S; Fujibayashi K; Goto-Hirano K; Kuwatsuru R
    HIV Med; 2022 May; 23(5):485-493. PubMed ID: 34821006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polypharmacy and potential drug-drug interactions among people living with HIV in the era of integrase strand transfer inhibitor-based antiretroviral therapy.
    Peng AT; Huang SH; Lee HY; Wu PY; Kuo HY; Hung CC
    Int J Antimicrob Agents; 2024 Feb; 63(2):107067. PubMed ID: 38141835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [HIV-related malignancies: state of art].
    Gobert A; Mounier N; Lavole A; Poizot-Martin I; Spano JP
    Bull Cancer; 2014 Nov; 101(11):1020-9. PubMed ID: 25418594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncologic complications of human immunodeficiency virus infection: changing epidemiology, treatments, and special considerations in the era of highly active antiretroviral therapy.
    Klibanov OM; Clark-Vetri R
    Pharmacotherapy; 2007 Jan; 27(1):122-36. PubMed ID: 17192166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolving Paradigms in HIV Malignancies: Review of Ongoing Clinical Trials.
    Bender Ignacio RA; Lin LL; Rajdev L; Chiao E
    J Natl Compr Canc Netw; 2018 Aug; 16(8):1018-1026. PubMed ID: 30099376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of adherence rates for antiretroviral, blood pressure, or mental health medications for HIV-positive patients at an academic medical center outpatient pharmacy.
    Langness J; Cook PF; Gill J; Boggs R; Netsanet N
    J Manag Care Spec Pharm; 2014 Aug; 20(8):809-14. PubMed ID: 25062074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaboration.
    D'Jaen GA; Pantanowitz L; Bower M; Buskin S; Neil N; Greco EM; Cooley TP; Henry D; Stem J; Dezube BJ; Stebbing J; Aboulafia DM
    Clin Lung Cancer; 2010 Nov; 11(6):396-404. PubMed ID: 21062730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of HIV-Related Lung Disease: Immunity, Infection, and Inflammation.
    Cribbs SK; Crothers K; Morris A
    Physiol Rev; 2020 Apr; 100(2):603-632. PubMed ID: 31600121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. State of the science and future directions for research on HIV and cancer: Summary of a joint workshop sponsored by IARC and NCI.
    Engels EA; Shiels MS; Barnabas RV; Bohlius J; Brennan P; Castilho J; Chanock SJ; Clarke MA; Coghill AE; Combes JD; Dryden-Peterson S; D'Souza G; Gopal S; Jaquet A; Lurain K; Makinson A; Martin J; Muchengeti M; Newton R; Okuku F; Orem J; Palefsky JM; Ramaswami R; Robbins HA; Sigel K; Silver S; Suneja G; Yarchoan R; Clifford GM
    Int J Cancer; 2024 Feb; 154(4):596-606. PubMed ID: 37715370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brief Report: Systemic Inflammation, Immune Activation, and Impaired Lung Function Among People Living With HIV in Rural Uganda.
    North CM; Muyanja D; Kakuhikire B; Tsai AC; Tracy RP; Hunt PW; Kwon DS; Christiani DC; Okello S; Siedner MJ
    J Acquir Immune Defic Syndr; 2018 Aug; 78(5):543-548. PubMed ID: 29683991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy-Induced Hepatotoxicity in HIV Patients.
    Bressan S; Pierantoni A; Sharifi S; Facchini S; Quagliarello V; Berretta M; Montopoli M
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of antineoplastic agents in patients with cancer who have HIV/AIDS.
    Rudek MA; Flexner C; Ambinder RF
    Lancet Oncol; 2011 Sep; 12(9):905-12. PubMed ID: 21570912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-medications and Drug-Drug Interactions in People Living with HIV in Turkey in the Era of Integrase Inhibitors.
    Yeşilbağ Z; Şengül Eİ; Şenoğlu S; Aydın ÖA; Karaosmanoğlu HK
    Curr HIV Res; 2020; 18(6):415-425. PubMed ID: 32787762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.